Biotech Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation August 1, 2022
Biotech BridgeBio Pharma Announces Positive Interim Results from a Phase 2 Trial of Infigratinib in Achondroplasia Demonstrating an Increase in Annualized Height Velocity of 1.52 cm/year in Children 5 Years of Age and Older, and Adds 5th Cohort to Trial August 1, 2022
Biotech Iovance Biotherapeutics to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 4, 2022 August 1, 2022
Biotech Allogene Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022 August 1, 2022
Biotech Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma August 1, 2022
Biotech Veru to Report Fiscal 2022 Third Quarter Financial Results, Host Conference Call on August 11th August 1, 2022
Search
press release
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
